| Sherri Lynn Hollick, MA, CCC-SLP | |
|
158 Candlewyck Dr, Avondale, PA 19311-1435 | |
| (610) 563-6337 | |
| Not Available |
| Full Name | Sherri Lynn Hollick |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 158 Candlewyck Dr, Avondale, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790091676 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL005696L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sherri Lynn Hollick, MA, CCC-SLP 158 Candlewyck Dr, Avondale, PA 19311-1435 Ph: (610) 444-8757 | Sherri Lynn Hollick, MA, CCC-SLP 158 Candlewyck Dr, Avondale, PA 19311-1435 Ph: (610) 563-6337 |
News Archive
Bowel Cancer UK welcomes the comments made by Mike Richards at the National Cancer Research Institute highlighting the lack of access to diagnostic tests for bowel cancer. Bowel Cancer UK has been campaigning on this issue for some time. The latest report from the charity, "Diagnosing bowel cancer early: right test, right time," highlights their concerns in more detail.
Thyroid hormones administered to female rats with high blood pressure led to encouraging cardiac improvements, according to a study in the American Journal of Physiology led by NYIT College of Osteopathic Medicine researcher Martin Gerdes.
Triple-S Management Corporation, the leading managed care company in Puerto Rico, today announced consolidated revenues of $584.8 million and consolidated operating income of $10.0 million for the three months ended March 31, 2014.
What if there were a solution to many of the global problems that confront us, from climate change to poverty to civil wars? There is, but it is starved of resources. It's called family planning, and it has been a victim of America's religious wars.
Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued non-final Actions Closing Prosecution in the reexamination proceedings for U.S. Pat. Nos. 6,833,252 ("the ‘252 patent") and 7,214,536 ("the ‘536 patent") that are owned by the Institut Pasteur and the Universite Pierre et Marie Cure (UPMC), and licensed to Cellectis, SA (ALCLS). For the second time, the PTO has rejected all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that were not provided to the patent examiners during prosecution by the patent applicants.
› Verified 3 days ago
Jennifer Williams, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24 Sullivan Chase Dr, Avondale, PA 19311 Phone: 484-643-9218 | |
Melssa Ann Mancini, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 113 Pine Valley Dr, Avondale, PA 19311 Phone: 610-368-4732 | |
Claire Mulligan, MS CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 432 Coote Dr, Avondale, PA 19311 Phone: 301-502-5704 Fax: 855-232-8604 |